Efficacy of 2‑(1‑hexyloxyethyl)‑2‑devinyl pyropheophorbide‑a in photodynamic therapy of human esophageal squamous cancer cells

  • Authors:
    • Dengpan Wu
    • Zhen Liu
    • Yanni Fu
    • Yuan Zhang
    • Nan Tang
    • Qin Wang
    • Liang Tao
  • View Affiliations

  • Published online on: July 25, 2013     https://doi.org/10.3892/ol.2013.1493
  • Pages: 1111-1119
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study investigated the effects of 2‑(1‑hexyloxyethyl)‑2‑devinylpyro pheophorbide‑a (HPPH)‑mediated photodynamic therapy (PDT) on in vitro cell survival and in vivo tumor growth derived from human esophageal squamous cancer cells (Eca109). A cell counting kit 8 (CCK8) assay was used to assess the phototoxicity of HPPH‑mediated PDT in cultured Eca109 cells. The inhibition of tumor growth was determined by the changes in the relative tumor volume (RTV) and tumor weight. The results revealed that HPPH, in the range of 0.005‑1 µg/ml, exhibited no cytotoxicity in the Eca109 cells without light exposure and that the in vitro efficiency of HPPH‑mediated PDT was higher compared with that of Photofrin®‑mediated PDT. The in vivo results indicated that graded doses of HPPH‑mediated PDT significantly inhibited the xenograft tumor growth derived from the Eca109 cells in a dose‑dependent manner. The inhibition efficacy of 0.6 and 1.0 mg/kg HPPH‑mediated PDT was similar to that of 10 mg/kg Photofrin‑mediated PDT. Furthermore, HPPH possessed a lower toxicity than Photofrin at the dose that achieved the same efficacy in mice bearing Eca109 subcutaneous tumors. The histopathological findings indicated that the tumor tissues in the photosensitizer (PS)‑treated mice demonstrated varying degrees of necrosis. HPPH and Photofrin exhibited vascular cytotoxicity on the treated tumors. In conclusion, the present study demonstrated that the phototoxicity of HPPH‑mediated PDT is higher than that of Photofrin‑mediated PDT of the same dose. HPPH possessed lower toxicity than Photofrin at the dose that achieved the same efficacy. Therefore, HPPH may be a promising agent for treating human esophageal squamous cell cancer (ESCC).
View Figures
View References

Related Articles

Journal Cover

October 2013
Volume 6 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu D, Liu Z, Fu Y, Zhang Y, Tang N, Wang Q and Tao L: Efficacy of 2‑(1‑hexyloxyethyl)‑2‑devinyl pyropheophorbide‑a in photodynamic therapy of human esophageal squamous cancer cells. Oncol Lett 6: 1111-1119, 2013.
APA
Wu, D., Liu, Z., Fu, Y., Zhang, Y., Tang, N., Wang, Q., & Tao, L. (2013). Efficacy of 2‑(1‑hexyloxyethyl)‑2‑devinyl pyropheophorbide‑a in photodynamic therapy of human esophageal squamous cancer cells. Oncology Letters, 6, 1111-1119. https://doi.org/10.3892/ol.2013.1493
MLA
Wu, D., Liu, Z., Fu, Y., Zhang, Y., Tang, N., Wang, Q., Tao, L."Efficacy of 2‑(1‑hexyloxyethyl)‑2‑devinyl pyropheophorbide‑a in photodynamic therapy of human esophageal squamous cancer cells". Oncology Letters 6.4 (2013): 1111-1119.
Chicago
Wu, D., Liu, Z., Fu, Y., Zhang, Y., Tang, N., Wang, Q., Tao, L."Efficacy of 2‑(1‑hexyloxyethyl)‑2‑devinyl pyropheophorbide‑a in photodynamic therapy of human esophageal squamous cancer cells". Oncology Letters 6, no. 4 (2013): 1111-1119. https://doi.org/10.3892/ol.2013.1493